The startup is in the early stages of clinical trials for its device, which is aimed at restoring function to paralysed patients. — Image by freepik
Neuralink Corp, the brain-implant company founded by Elon Musk, was set to implant its device in a second patient last Monday (June 24), but the surgery was halted due to the patient’s medical condition, said Michael Lawton, chief executive officer of the Barrow Neurological Institute.
The patient had health issues that made the person an unsuitable candidate for current participation in Neuralink’s study of its experimental device, Lawton said during a phone call. A replacement candidate will likely undergo the surgery next month at the Barrow facility.
